Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Cash & Current Investments: 2009-2011

Historic Cash & Current Investments for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $281.7 million.

  • Lexicon Pharmaceuticals' Cash & Current Investments rose 43.49% to $206.8 million in Q3 2012 from the same period last year, while for Sep 2012 it was $973.7 million, marking a year-over-year increase of 37.34%. This contributed to the annual value of $281.7 million for FY2011, which is 33.43% up from last year.
  • According to the latest figures from FY2011, Lexicon Pharmaceuticals' Cash & Current Investments is $281.7 million, which was up 33.43% from $211.1 million recorded in FY2010.
  • Lexicon Pharmaceuticals' 5-year Cash & Current Investments high stood at $281.7 million for FY2011, and its period low was $157.1 million during FY2009.
  • Moreover, its 3-year median value for Cash & Current Investments was $211.1 million (2010), whereas its average is $216.6 million.
  • Data for Lexicon Pharmaceuticals' Cash & Current Investments shows a peak YoY surged of 34.38% (in 2010) over the last 5 years.
  • Lexicon Pharmaceuticals' Cash & Current Investments (Yearly) stood at $157.1 million in 2009, then surged by 34.38% to $211.1 million in 2010, then spiked by 33.43% to $281.7 million in 2011.